Nachrichtenquelle: globenewswire | 16.06.2021, 00:08 | 105 | 0 VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2021 (GLOBE NEWSWIRE) AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced preliminary, unaudited financial results for the fiscal fourth quarter 2021. For the fiscal quarter ending June 30, 2021, AVITA Medical has to date realized total revenue in excess of its fiscal fourth quarter guidance range of $8.2 million to $8.6 million. Based on the strength of both RECELL commercial revenue and BARDA related revenue, the Company is raising fiscal Q4 guidance to be in the range of $9.5 - $9.7 million, consisting of $6.0 - $6.2 million of
ASX 200 rises again, Avita jumps, Shaver Shop sinks 16 June 2021 fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
Upstate HomeCare in Clinton participating in pilot antibody program to treat COVID-19 patients
Upstate HomeCare in Clinton is participating in a new pilot program to distribute antibody treatments to people diagnosed with coronavirus at non-hospital facilities like nursing homes.
Posted: Dec 22, 2020 2:58 PM
Posted By: WKTV
CLINTON, N.Y. Upstate HomeCare in Clinton is participating in a new pilot program to distribute antibody treatments to people diagnosed with coronavirus at non-hospital facilities like nursing homes.
The Special Projects for Equitable and Efficient Distribution (SPEED) pilot is a new federal allocation program offered through the Department of Health and Human Services, the Office of the Assistance Secretary for Preparedness and Response and the National Home Infusion Association.